Ischaemic stroke

• A randomized, placebo-controlled, double-blind, single-ascending-dose, Phase 1a/b study to assess the safety, pharmacokinetics, pharmacodyna … Pending
  2024-512196-12-00 1 "Acute Ischemic Stroke"
• Reduction of SystemiC Inflammation after ischemic stroke by intravenous DNase administration (ReSCInD) Pending
  2024-516701-22-00 4 "Reduction of SystemiC Inflammation after ischemic stroke by "
• “Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicen … Pending
  2024-520414-21-00 5 "Adult patients with a LVOS with large core within 9 hours of"
• StroKE34 Study Protocol: a randomized Controlled Phase IIa trial of intra-arterial Cd34+ Cells in acute ischemic Stroke Pending
  2025-520850-13-00 4 "Ischemic Stroke"
• A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusio … Pending
  2025-521269-28-00 4 "Acute ischemic stroke"
• Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (T … Pending
  2025-523065-16-00 6 "Non-cardioembolic ischemic stroke"
• A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting
  2022-501890-38-00 4 2024-02-16 "acute ischemic stroke"
• A confirmatory study to assess the efficacy of CEREBROLYSIN in post-acute ischemic stroke recovery Recruiting
  2025-521350-41-01 5 2025-10-10 "Stroke"
• Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION) Recruiting
  2024-519521-37-01 10 2025-07-30 "Acute ischemic stroke"
• Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting
  2023-509907-34-01 5 2025-03-10 "acute ischemic stroke"
• Allopurinol as a preventive drug in patients with high and very high cardiovascular risk, taking into account the presence of the long-COVID … Recruiting
  2024-517610-15-00 5 2024-03-28 "hyperuricemia, hypertension, ischemic stroke, intracerebral "
• A multicentre study evaluating the safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtP … Recruiting
  2024-518509-17-00 4 2022-01-10 "Acute ischemic stroke"
• A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke Halted
  2023-506178-11-00 5 2025-11-11 "Acute ischemic stroke"
• BRIGHT - A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug … Ended
  2022-502001-15-00 4 2023-12-05 "Acute Ischemic Stroke (AIS)"
• Phase IIa Aqueous Afamelanotide Solution Stroke Study Ended
  2022-500919-40-01 4 2023-03-10 "Arterial Ischaemic Stroke (AIS)"
• Glenzocimab for REperfusion in the setting of Endovascular therapy for brain infarctioN Ended
  2024-514352-32-00 10 2023-01-03 "Acute ischemic stroke"
• ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended
  2023-508454-26-00 6 2022-05-01 "Acute Ischemic Stroke"
• Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy Ended
  2023-509615-92-00 4 "Ischemic stroke with Large Core"

Showing 1–18 of 18 trials